CHU Marseille
- Address
- CHU la conception-Marseille, Marseille, France
CHU Marseille - ENT Research Center
CHU Marseille is a leading academic medical center conducting specialized research in otolaryngology and upper respiratory conditions. The facility demonstrates particular expertise in studying chronic inflammatory disorders of the sino-nasal region and developing innovative therapeutic approaches for ear, nose, and throat diseases.
- Chronic rhinosinusitis and purulent inflammatory conditions
- Long-term antibiotic therapy protocols for sino-nasal disorders
- Quality of life assessment in ENT pathologies
The center's research program emphasizes evidence-based treatment strategies for complex ENT conditions, particularly focusing on idiopathic purulent sinusitis in adult populations. Through multicentre randomized controlled trials, CHU Marseille contributes to advancing therapeutic standards using validated outcome measures such as the Sino-Nasal Outcome Test (SNOT-22) to evaluate patient-centered treatment efficacy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CHU Marseille
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Azithromycin Efficacy in Idiopathic Purulent Oedematous Sinusitis in Adults: A Multicentre Randomised Controlled Trial | Centre Hospitalier Intercommunal Creteil | Phase III | Not Recruiting | Oct 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azithromycin | 1 | Unknown | 2022-10-06 | 2022-10-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.